Chemical inhibitors of Abp γ target various kinases and signaling molecules implicated in its functional regulation. Staurosporine, a potent kinase inhibitor, disrupts multiple kinase-mediated pathways that likely include those directly phosphorylating Abp γ or closely related to its regulation. As these kinases become inhibited, Abp γ loses its phosphorylation cues, leading to its functional inhibition. Similarly, LY294002 and Wortmannin, both phosphoinositide 3-kinases (PI3K) inhibitors, impede a central signaling pathway that influences the activity of Abp γ. By blocking PI3K, these inhibitors prevent the cascade of events required for Abp γ to become active within the cell, thereby inhibiting its function. In the MAPK/ERK pathway, U0126 and PD98059 focus on MEK1/2 inhibition, which is essential for the downstream signaling that could regulate Abp γ's activity. The suppression of MEK1/2 activity by these chemicals interrupts the pathway necessary for Abp γ's function, leading to its inhibition.
Continuing with the theme of targeting kinases, SP600125 inhibits the JNK pathway, and SB203580 specifically inhibits the p38 MAP kinase. Both JNK and p38 MAP kinase are important in the regulation of proteins like Abp γ, and their inhibition can disrupt the signaling required for Abp γ's function. Rapamycin, by inhibiting mTOR, affects a major regulatory pathway that could control Abp γ's activity within the cell. Since mTOR signaling is crucial for many cellular processes, its inhibition by Rapamycin can suppress the function of Abp γ. Additionally, Dasatinib and PP2, both Src family kinase inhibitors, halt the activity of kinases that may phosphorylate or otherwise regulate Abp γ, leading to its functional suppression. Lastly, Sorafenib and Lapatinib target multiple receptor tyrosine kinases that are upstream of signaling pathways involving Abp γ. By inhibiting these kinases, Sorafenib and Lapatinib block the activation signals, leading to the inhibition of Abp γ's function within the cellular context. Each of these chemicals plays a distinct role in shutting down the pathways and processes that enable Abp γ to be functionally active, ensuring its inhibition.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine inhibits a wide range of protein kinases, which may include kinases directly phosphorylating Abp γ or are part of the signaling pathways Abp γ is involved in, leading to its functional inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits phosphoinositide 3-kinases (PI3K) which are involved in signaling pathways that can regulate the activity of Abp γ, resulting in its functional inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a PI3K inhibitor that by inhibiting this kinase can disrupt signaling pathways that regulate Abp γ activity, effectively inhibiting it. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 inhibits MEK1/2 in the MAPK/ERK pathway, which is connected to the regulation of Abp γ, leading to its functional inhibition due to reduced downstream signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 selectively inhibits MEK, which could play a role in signaling pathways involving Abp γ, thus its inhibition can functionally suppress Abp γ activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
SP600125 inhibits JNK, and if JNK is involved in the activation of Abp γ, its inhibition would result in the functional inhibition of Abp γ. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor, and by inhibiting p38 MAP kinase, it can disrupt pathways necessary for Abp γ activation, thus inhibiting its function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR which is often involved in pathways regulating proteins such as Abp γ, leading to its functional inhibition via downstream effects. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Dasatinib inhibits Src family kinases which may phosphorylate Abp γ or regulate its function, therefore its inhibition can lead to functional suppression of Abp γ. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
PP2 is another Src family kinase inhibitor, which by inhibiting these kinases, can lead to the functional inhibition of Abp γ if these kinases regulate its activity. |